{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:31Z","timestamp":1790668111582,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600507"],"award-info":[{"award-number":["81600507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12871-018-0487-7","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T22:27:37Z","timestamp":1519684057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Qiong","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-136X","authenticated-orcid":false,"given":"Qianqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"issue":"12","key":"487_CR1","first-page":"A4543","volume":"59","author":"MK Bogebjerg","year":"2012","unstructured":"Bogebjerg MK. No consensus on withholding angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before spinal anaesthesia. Dan Med J. 2012;59(12):A4543.","journal-title":"Dan Med J"},{"issue":"3A","key":"487_CR2","doi-asserted-by":"publisher","first-page":"38J","DOI":"10.1016\/j.amjcard.2007.05.013","volume":"100","author":"M Bohm","year":"2007","unstructured":"Bohm M. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now? Am J Cardiol. 2007;100(3A):38J\u201344J.","journal-title":"Am J Cardiol"},{"issue":"18","key":"487_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials. JAMA. 1995;273(18):1450\u20136.","journal-title":"JAMA"},{"issue":"10","key":"487_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140633","volume":"10","author":"CW Yang","year":"2015","unstructured":"Yang CW, Tzeng NS, Yin YJ, Li CH, Chen HA, Chiu SH, Ho SY, Huang HL. Angiotensin receptor blockers decrease the risk of major adverse cardiovascular events in patients with end-stage renal disease on maintenance dialysis: a Nationwide matched-cohort study. PLoS One. 2015;10(10):e0140633.","journal-title":"PLoS One"},{"issue":"2","key":"487_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/j.jvca.2007.12.020","volume":"22","author":"S Kheterpal","year":"2008","unstructured":"Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(2):180\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"487_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12688\/f1000research.2-12.v1","volume":"2","author":"R Nabbi","year":"2013","unstructured":"Nabbi R, Woehlck HJ, Riess ML. Refractory hypotension during general anesthesia despite preoperative discontinuation of an angiotensin receptor blocker. F1000Res. 2013;2:12.","journal-title":"F1000Res"},{"issue":"1","key":"487_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","volume":"92","author":"M Bertrand","year":"2001","unstructured":"Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001;92(1):26\u201330.","journal-title":"Anesth Analg"},{"issue":"5","key":"487_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1213\/ANE.0000000000000076","volume":"118","author":"RS Twersky","year":"2014","unstructured":"Twersky RS, Goel V, Narayan P, Weedon J. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients. Anesth Analg. 2014;118(5):938\u201344.","journal-title":"Anesth Analg"},{"issue":"5","key":"487_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/bja\/83.5.715","volume":"83","author":"DW Pigott","year":"1999","unstructured":"Pigott DW, Nagle C, Allman K, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth. 1999;83(5):715\u201320.","journal-title":"Br J Anaesth"},{"issue":"6","key":"487_CR10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0034-7094(09)70095-9","volume":"59","author":"VV da Costa","year":"2009","unstructured":"da Costa VV, Caldas AC, Nunes LG, Beraldo PS, Saraiva RA. Influence of angiotensin-converting enzyme inhibitors on hypotension after anesthetic induction: is the preoperative discontinuation of this drug necessary? Rev Bras Anestesiol. 2009;59(6):704\u201315.","journal-title":"Rev Bras Anestesiol"},{"issue":"3","key":"487_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342(3):145\u201353.","journal-title":"N Engl J Med"},{"issue":"6","key":"487_CR12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/00000539-199912000-00011","volume":"89","author":"SM Brabant","year":"1999","unstructured":"Brabant SM, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89(6):1388\u201392.","journal-title":"Anesth Analg"},{"issue":"9","key":"487_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jash.2014.05.017","volume":"8","author":"JJ Calloway","year":"2014","unstructured":"Calloway JJ, Memtsoudis SG, Krauser DG, Ma Y, Russell LA, Goodman SM. Hemodynamic effects of angiotensin inhibitors in elderly hypertensives undergoing total knee arthroplasty under regional anesthesia. J Am Soc Hypertens. 2014;8(9):644\u201351.","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"487_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1213\/00000539-199705000-00001","volume":"84","author":"F Ryckwaert","year":"1997","unstructured":"Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg. 1997;84(5):945\u20139.","journal-title":"Anesth Analg"},{"issue":"3","key":"487_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1213\/01.ANE.0000146521.68059.A1","volume":"100","author":"T Comfere","year":"2005","unstructured":"Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005;100(3):636\u201344. table of contents","journal-title":"Anesth Analg"},{"issue":"2","key":"487_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00000542-199408000-00006","volume":"81","author":"P Coriat","year":"1994","unstructured":"Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, Viars P. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81(2):299\u2013307.","journal-title":"Anesthesiology"},{"issue":"6","key":"487_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s11695-015-1862-9","volume":"26","author":"G Salvetti","year":"2016","unstructured":"Salvetti G, Di Salvo C, Ceccarini G, Abramo A, Fierabracci P, Magno S, Piaggi P, Vitti P, Santini F. Chronic renin-angiotensin system (RAS) blockade may not induce hypotension during Anaesthesia for bariatric surgery. Obes Surg. 2016;26(6):1303\u20137.","journal-title":"Obes Surg"},{"issue":"6","key":"487_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1213\/00000539-199206000-00005","volume":"74","author":"P Colson","year":"1992","unstructured":"Colson P, Saussine M, Seguin JR, Cuchet D, Chaptal PA, Roquefeuil B. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg. 1992;74(6):805\u20138.","journal-title":"Anesth Analg"},{"issue":"5","key":"487_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF03018973","volume":"47","author":"M Licker","year":"2000","unstructured":"Licker M, Schweizer A, Hohn L, Farinelli C, Morel DR. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth. 2000;47(5):433\u201340.","journal-title":"Can J Anaesth"},{"issue":"1","key":"487_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","volume":"126","author":"PS Roshanov","year":"2017","unstructured":"Roshanov PS, Rochwerg B, Patel A, Salehian O, Duceppe E, Belley-Cote EP, Guyatt GH, Sessler DI, Le Manach Y, Borges FK, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN prospective cohort. Anesthesiology. 2017;126(1):16\u201327.","journal-title":"Anesthesiology"},{"issue":"3","key":"487_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jvs.2015.09.048","volume":"63","author":"AM Steely","year":"2016","unstructured":"Steely AM, Callas PW, Bertges DJ. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy. J Vasc Surg. 2016;63(3):715\u201321.","journal-title":"J Vasc Surg"},{"key":"487_CR22","doi-asserted-by":"crossref","unstructured":"Zainudheen A, Scott IA, Caney X. Association of renin angiotensin antagonists with adverse perioperative events in patients undergoing elective orthopaedic surgery: a case-control study. Intern Med J. 2017;47(9):999\u20131005.","DOI":"10.1111\/imj.13487"},{"key":"487_CR23","unstructured":"Wells G, Shea B, O'Connell J: The Newcastle-Ottawa Scale (NOS) for Assessing The Quality of Nonrandomised Studies in Meta-analyses. ( http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp ). Accessed 15 Nov 2017."},{"issue":"5","key":"487_CR24","first-page":"722","volume":"32","author":"SB Akinci","year":"2004","unstructured":"Akinci SB, Ayhan B, Kanbak M, Aypar U. Refractory hypotension in a patient chronically treated with a long acting angiotensin-converting enzyme inhibitor. Anaesth Intensive Care. 2004;32(5):722\u20133.","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"487_CR25","first-page":"16","volume":"29","author":"DA Cozanitis","year":"2004","unstructured":"Cozanitis DA. The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia--a controlled case report. Anaesthesiol Reanim. 2004;29(1):16\u20138.","journal-title":"Anaesthesiol Reanim"},{"issue":"1","key":"487_CR26","first-page":"55","volume":"80","author":"J Trotter","year":"2012","unstructured":"Trotter J. Catecholamine-resistant hypotension following induction for spinal exploration. AANA J. 2012;80(1):55\u201360.","journal-title":"AANA J"},{"issue":"5","key":"487_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1213\/00000539-199911000-00012","volume":"89","author":"P Colson","year":"1999","unstructured":"Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999;89(5):1143\u201355.","journal-title":"Anesth Analg"},{"issue":"4","key":"487_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00000542-199604000-00005","volume":"84","author":"M Licker","year":"1996","unstructured":"Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology. 1996;84(4):789\u2013800.","journal-title":"Anesthesiology"},{"issue":"5","key":"487_CR29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1213\/00000539-199905000-00003","volume":"88","author":"D Eyraud","year":"1999","unstructured":"Eyraud D, Brabant S, Nathalie D, Fleron MH, Gilles G, Bertrand M, Coriat P. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg. 1999;88(5):980\u20134.","journal-title":"Anesth Analg"},{"issue":"4","key":"487_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00000539-200204000-00011","volume":"94","author":"K Meersschaert","year":"2002","unstructured":"Meersschaert K, Brun L, Gourdin M, Mouren S, Bertrand M, Riou B, Coriat P. Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study. Anesth Analg. 2002;94(4):835\u201340. table of contents","journal-title":"Anesth Analg"},{"issue":"4","key":"487_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/jhm.323","volume":"3","author":"DJ Rosenman","year":"2008","unstructured":"Rosenman DJ, McDonald FS, Ebbert JO, Erwin PJ, LaBella M, Montori VM. Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med. 2008;3(4):319\u201325.","journal-title":"J Hosp Med"},{"key":"487_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2016.04.132","volume":"217","author":"F Ricci","year":"2016","unstructured":"Ricci F, Di Castelnuovo A, Savarese G, Perrone Filardi P, De Caterina R. ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - a network meta-analysis. Int J Cardiol. 2016;217:128\u201334.","journal-title":"Int J Cardiol"},{"issue":"3","key":"487_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/hrt.76.3.207","volume":"76","author":"J Boldt","year":"1996","unstructured":"Boldt J, Rothe G, Schindler E, Doll C, Gorlach G, Hempelmann G. Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery? Heart. 1996;76(3):207\u201313.","journal-title":"Heart"},{"issue":"1","key":"487_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.1996.tb04401.x","volume":"40","author":"H Tohmo","year":"1996","unstructured":"Tohmo H, Karanko M. Angiotensin-converting enzyme inhibitors and anaesthesia. Acta Anaesthesiol Scand. 1996;40(1):132\u20133.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"14","key":"487_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","volume":"67","author":"M Evans","year":"2016","unstructured":"Evans M, Carrero JJ, Szummer K, Akerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction. J Am Coll Cardiol. 2016;67(14):1687\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"487_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00000542-200501000-00006","volume":"102","author":"A Morelli","year":"2005","unstructured":"Morelli A, Tritapepe L, Rocco M, Conti G, Orecchioni A, De Gaetano A, Picchini U, Pelaia P, Reale C, Pietropaoli P. Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics. Anesthesiology. 2005;102(1):12\u20139.","journal-title":"Anesthesiology"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0487-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T22:20:37Z","timestamp":1660515637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-018-0487-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1186\/s12871-018-0487-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}